Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

STLNSTLN
13 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in Starling Oncology, Inc.

Yes. Jane Street Group holds 852,163 shares of STLN (Starling Oncology), worth $4.6M, as of its Q2 2026 13F filing. It increased the position by 427,269 shares (+100.6%) from Q1 2026. Jane Street Group has held STLN since Q3 2025, across 4 quarterly 13F filings.

Current Value

$4.6M

Current Shares

852,163

Total Value Change

+$4.6M

Total Shares Change

+805,036

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
852,163
+100.6%
$4.6M0.0%$5.43
43
2026-Q1
Decreased
424,894
-47.1%
$1.3M0.0%$3.07
0
2025-Q4
Increased
803,315
+543.2%
$2.9M0.0%$3.56
42
2025-Q3
New
124,888
-
$435,8590.0%$3.49
33
2025-Q1
Exited
0
-100.0%
$00.0%$1.14
0
2024-Q4
Increased
127,659
+613.6%
$39,4470.0%$0.31
22
2024-Q3
Decreased
17,890
-43.4%
$5,8480.0%$0.33
0
2024-Q2
New
31,611
-
$14,5420.0%$0.46
28
2024-Q1
Exited
0
-100.0%
$00.0%$1.58
0
2023-Q4
New
28,187
-
$57,5020.0%$2.04
32
2023-Q3
Exited
0
-100.0%
$00.0%$1.40
0
2023-Q2
Decreased
22,974
-51.3%
$12,6400.0%$0.55
0
2023-Q1
New
47,127
-
$31,9470.0%$0.68
30

Other major holders of STLN: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used